|
1
|
Boateng S and Sanborn T: Acute myocardial
infarction. Dis Mon. 59:83–96. 2013. View Article : Google Scholar
|
|
2
|
Yellon DM and Hausenloy DJ: Myocardial
reperfusion injury. N Engl J Med. 357:1121–1135. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Turer AT and Hill JA: Pathogenesis of
myocardial ischemia-reperfusion injury and rationale for therapy.
Am J Cardiol. 106:360–368. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weiss JN, Korge P, Honda HM and Ping P:
Role of the mitochondrial permeability transition in myocardial
disease. Circ Res. 93:292–301. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fulda S and Debatin KM: Sensitization for
tumor necrosis factor-related apoptosis-inducing ligand-induced
apoptosis by the chemopreventive agent resveratrol. Cancer Res.
64:337–346. 2004. View Article : Google Scholar
|
|
6
|
Genade T and Lang DM: Resveratrol extends
lifespan and preserves glia but not neurons of the Nothobranchius
guentheri optic tectum. Exp Gerontol. 48:202–212. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang SJ, Bo QY, Zhao XH, Yang X, Chi ZF
and Liu XW: Resveratrol pre-treatment reduces early inflammatory
responses induced by status epilepticus via mTOR signaling. Brain
Res. 1492:122–129. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hao HD and He LR: Mechanisms of
cardiovascular protection by resveratrol. J Med Food. 7:290–298.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu JM and Hsieh TC: Resveratrol: a
cardioprotective substance. Ann N Y Acad Sci. 1215:16–21. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ungvari Z, Labinskyy N, Mukhopadhyay P, et
al: Resveratrol attenuates mitochondrial oxidative stress in
coronary arterial endothelial cells. Am J Physiol Heart Circ
Physiol. 297:H1876–H1881. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shen M, Wu RX, Zhao L, et al: Resveratrol
attenuates ischemia/reperfusion injury in neonatal cardiomyocytes
and its underlying mechanism. PLoS One. 7:e512232012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kuhl M, Sheldahl LC, Park M, Miller JR and
Moon RT: The Wnt/Ca2+ pathway: a new vertebrate Wnt
signaling pathway takes shape. Trends Genet. 16:279–283. 2000.
View Article : Google Scholar
|
|
13
|
Slusarski DC, Corces VG and Moon RT:
Interaction of Wnt and a Frizzled homologue triggers
G-protein-linked phosphatidylinositol signalling. Nature.
390:410–413. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sheldahl LC, Park M, Malbon CC and Moon
RT: Protein kinase C is differentially stimulated by Wnt and
Frizzled homologs in a G-protein-dependent manner. Curr Biol.
9:695–698. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou SS, He F, Chen AH, Hao PY and Song
XD: Suppression of rat Frizzled-2 attenuates
hypoxia/reoxygenation-induced Ca2+ accumulation in rat
H9c2 cells. Exp Cell Res. 318:1480–1491. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen M, Sun HY, Li SJ, Das M, Kong JM and
Gao TM: Nitric oxide as an upstream signal of p38 mediates
hypoxia/reoxygenation-induced neuronal death. Neurosignals.
17:162–168. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shin EJ, Schram K, Zheng XL and Sweeney G:
Leptin attenuates hypoxia/reoxygenation-induced activation of the
intrinsic pathway of apoptosis in rat H9c2 cells. J Cell Physiol.
221:490–497. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang C, Lin G, Wan W, et al: Resveratrol,
a polyphenol phytoalexin, protects cardiomyocytes against
anoxia/reoxygenation injury via the TLR4/NF-κB signaling pathway.
Int J Mol Med. 29:557–563. 2012.PubMed/NCBI
|
|
19
|
Porter AG and Jänicke RU: Emerging roles
of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kajstura J, Cheng W, Reiss K, et al:
Apoptotic and necrotic myocyte cell deaths are independent
contributing variables of infarct size in rats. Lab Invest.
74:86–107. 1996.PubMed/NCBI
|
|
21
|
Robich MP, Osipov RM, Nezafat R, et al:
Resveratrol improves myocardial perfusion in a swine model of
hypercholesterolemia and chronic myocardial ischemia. Circulation.
122(Suppl): S142–S149. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Burstein B, Maguy A, Clément R, et al:
Effects of resveratrol (trans-3,5,4′-trihydroxystilbene) treatment
on cardiac remodeling following myocardial infarction. J Pharmacol
Exp Ther. 323:916–923. 2007.
|
|
23
|
Eguchi M, Liu Y, Shin EJ and Sweeney G:
Leptin protects H9c2 rat cardiomyocytes from H2O2-induced
apoptosis. FEBS J. 275:3136–3144. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Das S, Alagappan VK, Bagchi D, et al:
Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol
consumption: a potential mechanism for resveratrol preconditioning
of the heart. Vascul Pharmacol. 42:281–289. 2005. View Article : Google Scholar
|
|
25
|
Das S, Tosaki A, Bagchi D, et al:
Resveratrol-mediated activation of cAMP response element-binding
protein through adenosine A3 receptor by Akt-dependent and
-independent pathways. J Pharmacol Exp Ther. 314:762–769. 2005.
View Article : Google Scholar
|
|
26
|
Moens AL, Claeys MJ, Timmermans JP and
Vrints CJ: Myocardial ischemia/reperfusion-injury, a clinical view
on a complex pathophysiological process. Int J Cardiol.
100:179–190. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bradamante S, Barenghi L, Piccinini F, et
al: Resveratrol provides late-phase cardioprotection by means of a
nitric oxide-and adenosine-mediated mechanism. Eur J Pharmacol.
465:115–123. 2003. View Article : Google Scholar
|
|
28
|
Das S, Cordis GA, Maulik N and Das DK:
Pharmacological preconditioning with resveratrol: role of
CREB-dependent Bcl-2 signaling via adenosine A3 receptor
activation. Am J Physiol Heart Circ Physiol. 288:H328–H335. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shimamoto A, Chong AJ, Yada M, et al:
Inhibition of Toll-like receptor 4 with eritoran attenuates
myocardial ischemia-reperfusion injury. Circulation. 114(Suppl):
I270–I274. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dudley J, Das S, Mukherjee S and Das DK:
Resveratrol, a unique phytoalexin present in red wine, delivers
either survival signal or death signal to the ischemic myocardium
depending on dose. J Nutr Biochem. 20:443–452. 2009. View Article : Google Scholar
|
|
31
|
Gasser RN: The interdependence of
hypertension, calcium overload, and coronary spasm in the
development of myocardial infarction. Angiology. 39:761–772. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Borutaite V and Brown GC: Mitochondria in
apoptosis of ischemic heart. FEBS Lett. 541:1–5. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hausenloy DJ and Yellon DM: The
mitochondrial permeability transition pore: its fundamental role in
mediating cell death during ischaemia and reperfusion. J Mol Cell
Cardiol. 35:339–341. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Borutaite V, Jekabsone A, Morkuniene R and
Brown GC: Inhibition of mitochondrial permeability transition
prevents mitochondrial dysfunction, cytochrome c release and
apoptosis induced by heart ischemia. J Mol Cell Cardiol.
35:357–366. 2003. View Article : Google Scholar
|
|
35
|
Pei JM, Kravtsov GM, Wu S, et al: Calcium
homeostasis in rat cardiomyocytes during chronic hypoxia: a time
course study. Am J Physiol Cell Physiol. 285:C1420–C1428. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Penna C, Perrelli MG and Pagliaro P:
Mitochondrial pathways, permeability transition pore, and redox
signaling in cardioprotection: therapeutic implications. Antioxid
Redox Signal. 18:556–599. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Koval A, Purvanov V, Egger-Adam D and
Katanaev VL: Yellow submarine of the Wnt/Frizzled signaling:
submerging from the G protein harbor to the targets. Biochem
Pharmacol. 82:1311–1319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012.
|
